- Report
- June 2022
- 73 Pages
Global
From €1746EUR$1,950USD£1,499GBP
- Report
- November 2024
- 66 Pages
Global
From €1746EUR$1,950USD£1,499GBP
- Report
- March 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- April 2024
- 264 Pages
Global
From €3223EUR$3,600USD£2,767GBP
- Report
- April 2024
- 141 Pages
Asia Pacific
From €1343EUR$1,500USD£1,153GBP
- Report
- October 2022
- 35 Pages
Global
From €3133EUR$3,500USD£2,690GBP
- Report
- May 2022
- 70 Pages
Global
From €2238EUR$2,500USD£1,921GBP
- Report
- May 2022
- 52 Pages
Global
From €2238EUR$2,500USD£1,921GBP
- Report
- May 2022
- 69 Pages
Global
From €2238EUR$2,500USD£1,921GBP
- Report
- April 2022
- 152 Pages
Global
From €3133EUR$3,500USD£2,690GBP
- Report
- April 2022
- 64 Pages
Global
From €3133EUR$3,500USD£2,690GBP
- Report
- November 2021
- 70 Pages
Global
From €3133EUR$3,500USD£2,690GBP
- Drug Pipelines
- March 2021
Global
From €3133EUR$3,500USD£2,690GBP
- Training
- November 2027
- 3 Hours
Global
€422EUR$488USD£350GBP
€482EUR$558USD£400GBP
- Training
- May 2027
- 3 Hours
Global
€422EUR$488USD£350GBP
€482EUR$558USD£400GBP
- Training
- November 2026
- 3 Hours
Global
€422EUR$488USD£350GBP
€482EUR$558USD£400GBP
- Report
- October 2025
- 82 Pages
Saudi Arabia
From €4029EUR$4,500USD£3,459GBP
- Report
- October 2025
- 96 Pages
Japan
From €4029EUR$4,500USD£3,459GBP
- Report
- September 2025
- 97 Pages
Italy
From €4029EUR$4,500USD£3,459GBP
- Report
- September 2025
- 88 Pages
United Kingdom
From €4029EUR$4,500USD£3,459GBP

Drug repositioning is a process of discovering new therapeutic uses for existing drugs. It is a cost-effective and time-efficient approach to drug discovery, as it eliminates the need to develop a new drug from scratch. The process involves analyzing existing drugs and their effects on the body, and then using this data to identify potential new uses for the drug. This can include treating different diseases, or even using the drug in combination with other drugs to create a more effective treatment.
Drug repositioning has become increasingly popular in recent years, as it can help reduce the cost and time associated with drug discovery. It also has the potential to reduce the risk of side effects, as the drug has already been tested and approved for use.
Companies in the drug repositioning market include GVK Biosciences, Novartis, Pfizer, and Johnson & Johnson. Show Less Read more